SLPI anticorps (Middle Region)

N° du produit ABIN318889

Détail du produit anti-SLPI anticorps

Antigène: SLPI (Secretory Leukocyte Peptidase Inhibitor (SLPI))

Épitope: Middle Region

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SLPI est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Purification: Purified

Immunogène: A 17 amino acid peptide located near the centre of human SLPI.

Isotype: IgG

Information d'application

Indications d'application: Western Blot: 1.0 - 2.0g/mL, detects a band of approximately 14 kDa in Daudi cell lysates.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 1.0 mg/mL

Buffer: Phosphate buffered saline containing 0.02 % Sodium Azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur SLPI

Antigène: SLPI (Secretory Leukocyte Peptidase Inhibitor (SLPI))

Autre désignation: Antileukoproteinase (ALP) (SLPI Produits)

Synonymes: anticorps ALK1, anticorps ALP, anticorps BLPI, anticorps HUSI, anticorps HUSI-I, anticorps MPI, anticorps WAP4, anticorps WFDC4, anticorps MATN4, anticorps SLPI, anticorps ckpi, anticorps secretory leukocyte peptidase inhibitor, anticorps antileukoproteinase, anticorps SLPI, anticorps Slpi, anticorps LOC102174044

Sujet: SLPI is a 14kD non-glycosylated protein produced by secretory cells in the respiratory, genital and lacrimal glands, and by macrophages, B-cells and neutrophils. The functions of SLPI are diverse. The SLPI protein inhibits protease activity at sites of inflammation, protecting tissues against protease mediated damage and it possesses anti-microbial/anti-viral activity. In addition, SLPI has been reported to exhibit anti-inflammatory properties, regulating lipopolysaccharide induced activation of NF-kappa beta in peripheral blood monocytes.Synonyms: BLPI, HUSI-1, Mucus proteinase inhibitor, Protease inhibitor WAP4, SLPI, Secretory leukocyte protease inhibitor, Seminal proteinase inhibitor, WAP four-disulfide core domain protein 4, WAP4, WFDC4

ID gène: 9606

UniProt: P03973